We enjoyed having Jeff Waldron, a Brown Alum and his class reunion organizer visit with us at #LegorretaCancerCenter to learn about progress and future directions at the cancer center. Exciting things are happening at @BrownUniversity, @BrownMedicine, and @BrownUnivHealth. @ShiOnaCo @rwsobol @LiangChengMD @SenduraiMani @bcarneiro7 @LauraStroudPhD @npub15w47...u5t9 @SheRiseRogersMD @SeanLawler20 @DawsonStemCell

GSK3B directs DNA repair choice and determines tumor response to PARP1 inhibition independent of BRCA1

JCI - GSK3B directs DNA repair choice and determines tumor response to PARP1 inhibition independent of BRCA1

Tumour-reactive heterotypic CD8 T cell clusters from clinical samples https://www.nature.com/articles/s41586-025-09754-w

RAS(ON) multi-selective inhibition drives antitumor immunity in preclinical models of NRAS-mutant melanoma https://aacrjournals.org/cancerimmunolres/article/doi/10.1158/2326-6066.CIR-25-0744/767109/RAS-ON-multi-selective-inhibition-drives-antitumor

ZAK activation at the collided ribosome https://www.nature.com/articles/s41586-025-09772-8